Catalyst Wire Dossier Catalyst Wire Dossier

Empagliflozin (Jardiance)

empagliflozin · Boehringer Ingelheim and Eli Lilly
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Empagliflozin (Jardiance), covering 2018-04-02 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart [Phase 3]

See pricing